Differences in cardiorespiratory fitness by gonadotropin-releasing hormone agonist treatment before and after testosterone in transgender adolescents
Natalie Nokoff(Children's Hospital Colorado), Kerrie L. Moreau(VA Eastern Colorado Health Care System), Travis Nemkov(University of Colorado Anschutz Medical Campus), Megan M. Kelsey(Harvard University), Samantha Bothwell(Colorado School of Public Health), Amy C. Keller(University of Colorado Anschutz Medical Campus), Melanie Cree‐Green(University of Colorado Boulder), Kristen J. Nadeau(Children's Hospital Colorado)
Cited by 2
Related Papers
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
|Journal of Hepatology|2018|938
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556